The conference was attended by approximate 200 experts representing a wide range of views on pharmaceutical policy issues: the pharmaceutical industry, public and private drug plans, government, nonprofit organizations, health professions, and academia. Over 90% of the participants at the conference said that the pharmacare system in Canada needed to be reformed. Data presented here are from audience polling at the Pharmacare 2020 conference held on 26/27 Feb 2013 in Vancouver. Polling was conducted electronically and was strictly voluntary and anonymous. 173 of approximately 200 delegates participated in polling (>80% participation rate). 168 delegates (>80%) answered questions about the sector in which they work. Sector-specific results are not reported for groups with 5 or fewer polling participants (e.g., private insurers and representatives of “other” sectors). The text of some questions and answers has been edited slightly to fit presentation slides. Some percentages do not add up to 100 because of rounding.

2. Methods
• Data presented here are from audience polling at the Pharmacare 2020
conference held on 26/27 Feb 2013 in Vancouver.
• Polling was conducted electronically and was strictly voluntary and
anonymous.
• 173 of approximately 200 delegates participated in polling (>80%
participation rate).
• 168 delegates (>80%) answered questions about the sector in which
they work.
• Sector-specific results are not reported for groups with 5 or fewer
polling participants (e.g., private insurers and representatives of
“other” sectors).
• The text of some questions and answers has been edited slightly to fit
presentation slides.
• Some percentages do not add up to 100 because of rounding.

4. Which category best describes the sector in which you work?
Health
Rx Industry professions Non-profits Public sector Academia Others
1
1
1
1
1
1
1
1
1 1
1 1 1
1 1 1
1 1 1
1 1 1
1 1 1
1 1 1
1 1 1
1 1 1
All 1
1
1
1
1
1
1
1
1
1
1
1
1
1
1 1 1 1
Delegates 1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1 1 1 1
1 1 1 1
1 1 1 1
1 1 1 1
1 1 1 1 1
1 1 1 1 1
1 1 1 1 1
1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
N 37 26 14 36 45 10
Where do you currently live/work?
BC Prairies ON QC Atlantic Other
1
1
1
1
1
1
1
1
1
1 1
1 1
1 1
1 1
1 1
1 1
1 1
All 1
1
1
1
1
1
1
1
1 1
Delegates 1
1
1
1
1
1
1
1
1
1
1 1
1 1
1 1
1 1
1 1
1 1
1 1 1
1 1 1
1 1 1
1 1 1
1 1 1
1 1 1
1 1 1
1 1 1
1 1 1 1
1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
N 76 20 60 7 2 3

5. What do you see as the primary challenge in pharmacare policy today?
Canadians Too much Little control Inappropriate
Little incentive cannot afford financial burden over Rx prescription drug Other / I don’t
for Rx innovation needed Rx on patients expenditures use know
All
Delegates
1
1
1
1 1 1
1 1 1
1 1 1
1 1 1
1 1 1 1
1 1 1 1 1
1 1 1 1 1
1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
% 6 21 13 27 22 11

6. What do you see as the primary challenge in pharmacare policy today?
Canadians Too much Little control Inappropriate
Little incentive cannot afford financial burden over Rx prescription drug Other / I don’t
for Rx innovation needed Rx on patients expenditures use know
Rx
Industry 1 1
1
1 1
1
1 1
1 1
1
1
1 1
1 1
1
1
1 1
1 1
1 1
1
1
1 1
1 1 1 1
1 1
1
1
1 1
1 1
1 1
1 1
1 1
1
% 20 13 7 7 27 27
Health
Professions 1
1
1
1
1
1
1
1
1 1
1
1
1 1
1
1
1 1
1
1
1 1
1 1
1
1
1 1
1 1
1 1
1 1
1
1 1
1 1
1 1
1 1
1 1
1
% 4 26 9 39 13 9
1
1
1
Non-profits 1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1 1 1
1
1 1
1 1
1
1
1 1
1 1
1 1
1 1
1
1 1 1 1 1
% 0 57 14 7 14 7
Public
Sector 1
1
1
1
1
1 1
1
1
1 1
1
1
1 1
1
1
1 1
1
1 1
1 1
1
1
1 1
1 1
1 1
1 1
1
1 1
1 1
1 1
1 1
1 1
1
% 3 12 9 38 29 9
Academia
1
1
1
1 1
1
1
1 1
1 1
1
1
1 1
1 1
1 1
1
1 1
1 1
1 1
1
1
1 1
1 1
1 1
1
1
1 1
1 1
1 1
1 1
1
% 2 21 26 30 16 5

8. Which of these is the most/least important goal for pharmacare reform?
Incentives for Appropriateness Access to needed Choice regarding Equity in the Efficiency in
investment and of prescribing Rx for all Rx and/or distribution of Rx management of
innovation and use Canadians insurance costs Rx expenditures
1
1
1
1
1
1
1
1
1
1
1
1
1
1 1 1
All 1
1
1
1 1
1
1
1 1 1 1 1 1
Delegates 1 1 1
1 1 1
1 1 1
1 1
1 1
1
1
1
1
1
1
1
1
1
Net % -56 +12 +64 -19 -10 +8

9. Which of these is the most important goal for pharmacare reform?
Incentives for Appropriateness Access to needed Choice regarding Equity in the Efficiency in
investment and of prescribing Rx for all Rx and/or distribution of Rx management of
innovation and use Canadians insurance costs Rx expenditures
1
1
1
1
Rx 1
1
1
1
1
1
1
1
1
1
1
Industry 1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1 1
1 1
1
1
1 1
1 1
1 1 1
% 0 10 72 10 3 3
1
1
1
Health 1
1
1
1
1
1
1
1
1
1
1
Professions 1
1
1
1
1
1
1
1
1
1
1
1
1
1 1
1
1 1
1
1
1 1
1 1
1
1
1 1
1 1
1 1
1
% 5 10 70 0 0 15
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Non-profits 1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1 1
1
1 1
1 1
1
1 1 1
% 0 6 82 12 0 0
Public 1
1
1
1
1
Sector 1
1
1
1
1
1
1
1
1 1
1
1
1 1
1 1
1
1 1
1 1
1
1
1 1
1 1
1
1
1 1
1 1
1
1 1
1 1
1 1 1
1
% 3 23 51 0 3 20
1
1
1
1
1
1
1
1
Academia 1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1 1
1 1
1
1
1 1
1 1 1
1
1 1 1 1
% 0 12 68 2 5 12

10. Which of these is the least important goal for pharmacare reform?
Incentives for Appropriateness Access to needed Choice regarding Equity in the Efficiency in
investment and of prescribing Rx for all Rx and/or distribution of Rx management of
innovation and use Canadians insurance costs Rx expenditures
Rx 1
1
1
1
1
Industry 1
1
1
1
1
1
1
1
1
1 1
1
1
1 1
1
1
1 1
1
1
1 1
1
1
1 1 1 1
1 1
1
1 1
1 1
1 1
1 1
1
% 52 7 0 7 26 7
Health
1
1
1
Professions 1
1
1
1
1
1
1
1
1
1
1
1
1 1
1
1
1 1
1
1
1 1
1 1
1
1 1
1 1
1
1
1 1
1 1
1
1
1 1
1 1
1 1
1
% 47 0 0 32 16 5
Non-profits 1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1 1
1 1
1
1
1 1
1 1
1
1
1 1
1 1
1
1
1 1 1
1 1
1 1
1 1 1 1 1
% 50 0 6 19 19 6
1
Public 1
1
1
1
1
1
1
1
1
1
1
Sector 1
1
1
1
1
1
1
1
1
1
1
1 1
1
1 1
1 1
1
1 1
1 1
1
1
1 1
1 1
1
1
1 1
1 1
1
% 66 0 0 19 16 0
1
1
1
Academia 1
1
1
1
1
1
1
1 1
1
1 1
1
1
1 1
1
1
1 1
1
1
1 1
1
1
1 1
1
1
1 1
1
1
1 1
1
1
1 1
1
1 1 1 1
% 58 0 3 37 0 3

12. Overall do Canadians pay reasonable prices for patented drugs?
Canadians pay more
Canadians pay far than they should Canadians pay a Canadians pay too
too much have to reasonable amount little Other / I don’t know
All
Delegates
1
1 1
1 1
1 1
1 1 1
1 1 1
1 1 1
1 1 1
1 1 1
1 1 1
1 1 1
1 1 1 1
1 1 1 1
1 1 1 1
1 1 1 1
1 1 1 1
1 1 1 1
% 31 33 25 0 12

13. Overall do Canadians pay reasonable prices for patented drugs?
Canadians pay more
Canadians pay far than they should Canadians pay a Canadians pay too
too much have to reasonable amount little Other / I don’t know
1
1
1
1
Rx 1
1
1
1
1
1
1
1
1
1
1
Industry 1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1 1
1 1
1 1
1
1
1 1
1 1
1 1
1
% 10 10 71 0 10
Health
1
1
Professions 1
1
1
1
1
1
1
1
1
1
1
1
1
1
1 1
1
1
1 1
1
1
1 1
1 1
1
1 1
1 1
1
1
1 1
1 1
1
1
1 1
1 1
1 1
% 35 46 15 0 4
1
1
1
1
1
Non-profits 1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1 1
1
1
1 1
1
1
1 1
1
1
1 1
1
1
1 1
1 1
1 1
1
1 1 1 1
% 8 62 23 0 8
Public
1
1
Sector 1
1
1
1
1
1
1
1 1
1
1
1 1
1
1
1 1
1
1
1 1
1
1
1 1
1 1
1 1
1
1
1 1
1 1
1 1
1
1
1 1
1 1
1 1
1
% 45 29 13 0 13
Academia 1
1
1 1
1
1
1 1
1
1
1 1
1
1
1 1
1
1
1 1
1 1
1
1 1
1 1
1
1
1 1
1 1
1
1
1 1
1 1
1 1
1
1 1 1 1
% 36 38 8 0 18

14. Which of these would be the best/worst approach to patented drug pricing?
Stronger Single-payer to Public/private Collaboration Public/private
regulation of list negotiate system- competition for among public collaboration for Other / I don’t
prices paid by all wide rebates rebates plans for rebates rebates know
1
1
1
1
1
1
1
1
1 1 1
All 1
1
1
1 1
1
1
1
1
1
1
1 1 1 1 1 1
Delegates 1 1 1 1 1
1 1 1
1 1 1
1 1
1 1
1
1
1
1
1
1
1
Net % -10 +42 -42 +6 -1 +7

15. Which of these would be the best approach to patented drug pricing?
Stronger Single-payer to Public/private Collaboration Public/private
regulation of list negotiate system- competition for among public collaboration for Other / I don’t
prices paid by all wide rebates rebates plans for rebates rebates know
Rx
Industry 1
1
1
1
1
1 1
1
1
1 1
1 1
1
1
1 1
1 1 1
1 1
1
1
1 1
1 1
1 1
1 1 1
1
1
1 1
1 1
1 1
1 1
1 1
1
% 18 14 11 29 7 21
Health 1
1
1
1
1
1
1
1
1
1
1
Professions 1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1 1
1
1
1 1 1 1
1
1 1
1 1
1 1
1 1
1 1
% 4 63 8 8 13 4
Non-profits
1
1
1
1
1
1 1
1
1
1 1
1
1
1 1
1 1
1
1
1 1
1 1
1
1 1
1 1 1 1
1 1
1
1
1 1
1 1
1 1
1 1
1 1
1
% 8 25 8 8 33 17
Public
Sector 1
1
1
1
1
1
1
1
1 1
1
1
1 1
1
1
1 1
1 1 1
1 1
1
1 1
1 1 1
1 1
1 1
1
1
1 1
1 1
1 1
1 1
1 1
1
% 14 36 7 11 21 11
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Academia 1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1 1
1
1
1 1
1
1 1 1 1 1
% 9 82 3 0 3 3